Advanced Computational Framework for Predicting Multimodal Treatment Efficacy in Triple-Negative Breast Cancer

Authors

  • Chris Perez PhD
  • Charlie Scott Associate Professor
  • Kai Phillips Professor
  • Kim Carter MD

Keywords:

Triple-negative breast cancer, Computational model, Treatment efficacy prediction, Machine learning algorithms, Personalized medicine, Genomic data integration, Proteomic analytics

Abstract

The study develops a sophisticated computational model to enhance the prediction accuracy of multimodal treatment outcomes for triple-negative breast cancer (TNBC). Utilizing machine learning algorithms, the model integrates genomic, proteomic, and clinical data to offer real-time predictive analytics. Results indicate a substantial increase in prediction accuracy, supporting personalized treatment plans. This framework could revolutionize TNBC management by optimizing therapeutic strategies.

Author Biographies

Chris Perez, PhD

PhD
Harvard University
Cambridge, MA 02138, United States

Charlie Scott, Associate Professor

Associate Professor
University of Oxford
Oxford OX1 2JD, United Kingdom

Kai Phillips, Professor

Professor
Ludwig Maximilian University of Munich
Geschwister-Scholl-Platz 1, 80539 Munich, Germany

Kim Carter, MD

MD
University of Toronto
27 King's College Cir, Toronto, ON M5S, Canada

References

Бортный Н.А., Сиротников Е.Л., Бортная Т.Н. Нарушения гемодинамики у пациентов с инфарктом миокарда левого желудочка в разные стадии его ремоделирования по данным лучевых методов исследования // Russian Electronic Journal of Radiology. — 2012. — Том 2. — № 2 (Матер. VI Всерос. Нац. Конгресса лучевых диагностов и терапевтов «Радиология — 2012», 30 мая — 1 июня 2012, г. Москва). — С. 93-94

Published

2024-12-18

Issue

Section

Articles